Search
for
Sort by
Research 151–180 of 846
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Evidence-based approach to cutaneous hyperandrogenism in women
- Hirsutism: Diagnosis and management
- Redefining hormone resistance in prostate cancer
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Nonclassic congenital adrenal hyperplasia
- The clinical management of hirsutism
- Management of CAH during pregnancy
- Endocrine evaluation of hirsutism
- Gender-Affirming Hormone Therapy for Transgender Men
- Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Hirsutism: diagnosis and treatment
- Male hormonal contraception: looking back and moving forward
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Female Adolescent Hair Disorders
- Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours